Judy Hayler

Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway

Ian C. Bruce, Mohammed Shahid Akhlaq, Graham C. Bloomfield et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 47 citations · Full text

Signal Transduction, Signaling Pathway, Chemoprevention Strategy +10

Conjugate Addition of 2- and 4-Pyridylcuprates:  An Expeditious Asymmetric Synthesis of Natural (−)-Evoninic Acid

Alan C. Spivey, Lena Shukla, Judy Hayler · Organic Letters · 2007 · 42 citations

Design and Synthesis of Thrombin Inhibitors:  Analogues of MD-805 with Reduced Stereogenicity and Improved Potency

Derek E. Brundish, Alice Bull, Vera Donovan et al. · Journal of Medicinal Chemistry · 1999 · 29 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Thrombin Inhibitors +15

Amidine protection for solution phase library synthesis

Christine Bailey, Emma L. Baker, Judy Hayler et al. · Tetrahedron Letters · 1999 · 12 citations

Combinatorial Chemistry, Amidine Protection, Peptide Synthesis +3

the design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors

Judy Hayler, Peter D. Kane, Darren LeGrand et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 11 citations · Full text

Thrombosis, Medicinal Chemistry, Oral Bioavailability +13